nach oben

Quality of Life Research

Erschienen in:

21.03.2019

Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome

verfasst von: Livia Guadagnoli, Ece A. Mutlu, Bethany Doerfler, Ammoura Ibrahim, Darren Brenner, Tiffany H. Taft

Erschienen in: Quality of Life Research | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Food-related quality of life (FRQoL) evaluates the impact of diet, eating behaviors, and food-related anxiety on a person’s quality of life. This is the first study to evaluate FRQoL in inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), two illnesses where food and diet are of importance.

Methods

One hundred seventy-five participants (80 IBS, 95 IBD) participated in the study by completing measures evaluating FRQoL, psychological distress, and health-related quality of life. Primary analyses evaluated differences in FRQoL between IBD and IBS patients. Secondary analyses compared differences based on remission status, dietary use, and dietary consultation, as well as evaluated potential predictors of FRQoL.

Results

IBD patients in remission report the highest FRQoL (IBD-remission: 91.2 (26.5) vs. IBD-active: 67.7 (19.6) and IBS-active: 67.6 (18.3), p < .001). Using more dietary treatments is associated with decreased FRQoL for IBS (r = − 0.23, p < .05) and IBD patients (r = − 0.31, p < .01). IBS patients are more likely to use dietary treatments than IBD (IBS = 81% vs. IBD = 64%, p < .01), with self-directed diets being the most commonly used approach. Symptom severity is the strongest predictor of FRQoL in both groups (IBD: R² = .27, p < .01; IBS: R² = .23, p < .001).

Conclusion

FRQoL is a unique construct for IBD and IBS patients that can be influenced by several clinical and dietary factors, including number of diets and type of diet used, depending on the diagnosis. Thus, FRQoL should be considered when working with both IBD and IBS patients.

Nur mit Berechtigung zugänglich

Ballou, S., & Keefer, L. (2017). Psychological interventions for irritable bowel syndrome and inflammatory bowel diseases. Clinical And Translational Gastroenterology, 8, e214. https://doi.org/10.1038/ctg.2016.69.CrossRefPubMedPubMedCentral

Peery, A. F., Dellon, E. S., Lund, J., Crockett, S. D., McGowan, C. E., Bulsiewicz, W. J., et al. (2012). Burden of Gastrointestinal disease in the United States: 2012 update. Gastroenterology, 143(5), 1179–1187.e1173. https://doi.org/10.1053/j.gastro.2012.08.002.CrossRefPubMedPubMedCentral

Chey, W. D., Kurlander, J., & Eswaran, S. (2015). Irritable bowel syndrome: A clinical review. JAMA, 313(9), 949–958. https://doi.org/10.1001/jama.2015.0954.CrossRefPubMed

Zhang, Y. Z., & Li, Y. Y. (2014). Inflammatory bowel disease: Pathogenesis. World Journal of Gastroenterology, 20(1), 91–99. https://doi.org/10.3748/wjg.v20.i1.91.CrossRefPubMedPubMedCentral

Barbara, G., Cremon, C., & Stanghellini, V. (2014). Inflammatory bowel disease and irritable bowel syndrome: Similarities and differences. Current Opinion in Gastroenterology, 30(4), 352–358. https://doi.org/10.1097/mog.0000000000000070.CrossRefPubMed

Ballou, S., Bedell, A., & Keefer, L. (2015). Psychosocial impact of irritable bowel syndrome: A brief review. World Journal of Gastrointestinal Pathophysiology, 6(4), 120–123. https://doi.org/10.4291/wjgp.v6.i4.120.CrossRefPubMedPubMedCentral

Casati, J., & Toner, B. B. (2000). Psychosocial aspects of inflammatory bowel disease. Biomed Pharmacother, 54(7), 388–393. https://doi.org/10.1016/s0753-3322(01)80006-8.CrossRefPubMed

Amouretti, M., Le Pen, C., Gaudin, A. F., Bommelaer, G., Frexinos, J., Ruszniewski, P., et al. (2006). Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterologie Clinique et Biologique, 30(2), 241–246.CrossRef

Blondel-Kucharski, F., Chircop, C., Marquis, P., Cortot, A., Baron, F., Gendre, J. P., et al. (2001). Health-related quality of life in Crohn’s disease: A prospective longitudinal study in 231 patients. The American Journal of Gastroenterology, 96(10), 2915–2920. https://doi.org/10.1111/j.1572-0241.2001.4681_b.x.CrossRefPubMed

10.

Casellas, F., Vivancos, J. L., Sampedro, M., & Malagelada, J. R. (2005). Relevance of the phenotypic characteristics of Crohn’s disease in patient perception of health-related quality of life. The American Journal of Gastroenterology, 100(12), 2737–2742. https://doi.org/10.1111/j.1572-0241.2005.00360.x.CrossRefPubMed

11.

Casellas, F., Lopez-Vivancos, J., Badia, X., Vilaseca, J., & Malagelada, J. R. (2000). Impact of surgery for Crohn’s disease on health-related quality of life. The American Journal of Gastroenterology, 95(1), 177–182. https://doi.org/10.1111/j.1572-0241.2000.01681.x.CrossRefPubMed

12.

De Gucht, V. (2015). Illness perceptions mediate the relationship between bowel symptom severity and health-related quality of life in IBS patients. Quality of Life Research, 24(8), 1845–1856. https://doi.org/10.1007/s11136-015-0932-8.CrossRefPubMedPubMedCentral

13.

Guthrie, E., Jackson, J., Shaffer, J., Thompson, D., Tomenson, B., & Creed, F. (2002). Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease. The American Journal of Gastroenterology, 97(8), 1994–1999. https://doi.org/10.1111/j.1572-0241.2002.05842.x.CrossRefPubMed

14.

Dean, B. B., Aguilar, D., Barghout, V., Kahler, K. H., Frech, F., Groves, D., et al. (2005). Impairment in work productivity and health-related quality of life in patients with IBS. The American Journal of Managed Care, 11(Suppl 1), 17–26.

15.

Koloski, N. A., Boyce, P. M., Jones, M. P., & Talley, N. J. (2012). What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful? Quality Life Research, 21(5), 829–836. https://doi.org/10.1007/s11136-011-9985-5.CrossRef

16.

Daniel, J. M. (2002). Young adults’ perceptions of living with chronic inflammatory bowel disease. Gastroenterology Nursing, 25(3), 83–94.CrossRef

17.

Taft, T. H., Keefer, L., Leonhard, C., & Nealon-Woods, M. (2009). Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflammatory Bowel Diseases, 15(8), 1224–1232. https://doi.org/10.1002/ibd.20864.CrossRefPubMedPubMedCentral

18.

Taft, T. H., Keefer, L., Artz, C., Bratten, J., & Jones, M. P. (2011). Perceptions of illness stigma in patients with inflammatory bowel disease and irritable bowel syndrome. Quality Life Research, 20(9), 1391–1399. https://doi.org/10.1007/s11136-011-9883-x.CrossRef

19.

Taft, T. H., Ballou, S., & Keefer, L. (2013). A preliminary evaluation of internalized stigma and stigma resistance in inflammatory bowel disease. Journal of Health Psychology, 18(4), 451–460. https://doi.org/10.1177/1359105312446768.CrossRefPubMed

20.

Bohn, L., Storsrud, S., Tornblom, H., Bengtsson, U., & Simren, M. (2013). Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. The American Journal of Gastroenterology, 108(5), 634–641. https://doi.org/10.1038/ajg.2013.105.CrossRefPubMed

21.

Gustafsson, U., & Draper, A. (2009). The social aspects of food and nutrition. Journal of Human Nutrition and Dietetics, 22(2), 87–88. https://doi.org/10.1111/j.1365-277X.2009.00951.x.CrossRefPubMed

22.

Kakodkar, S., Farooqui, A. J., Mikolaitis, S. L., & Mutlu, E. A. (2015). The specific carbohydrate diet for inflammatory bowel disease: A case series. Journal of the Academy of Nutrition and Dietetics, 115(8), 1226–1232. https://doi.org/10.1016/j.jand.2015.04.016.CrossRefPubMed

23.

Burgis, J. C., Nguyen, K., Park, K. T., & Cox, K. (2016). Response to strict and liberalized specific carbohydrate diet in pediatric Crohn’s disease. World Journal of Gastroenterology, 22(6), 2111–2117. https://doi.org/10.3748/wjg.v22.i6.2111.CrossRefPubMedPubMedCentral

24.

Staudacher, H. M., Irving, P. M., Lomer, M. C., & Whelan, K. (2014). Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nature Reviews Gastroenterology & Hepatology, 11(4), 256–266. https://doi.org/10.1038/nrgastro.2013.259.CrossRef

25.

Marsh, A., Eslick, E. M., & Eslick, G. D. (2016). Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. European Journal of Nutrition, 55(3), 897–906. https://doi.org/10.1007/s00394-015-0922-1.CrossRefPubMed

26.

Drisko, J., Bischoff, B., Hall, M., & McCallum, R. (2006). Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. Journal of the American College of Nutrition, 25(6), 514–522.CrossRef

27.

Moayyedi, P., Quigley, E. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., et al. (2015). The effect of dietary intervention on irritable bowel syndrome: A systematic review. Clinical and Translational Gastroenterology, 6, e107. https://doi.org/10.1038/ctg.2015.21.CrossRefPubMedPubMedCentral

28.

Lomer, M. C., Gourgey, R., & Whelan, K. (2014). Current practice in relation to nutritional assessment and dietary management of enteral nutrition in adults with Crohn’s disease. Journal of Human Nutrition and Dietetics, 27(Suppl 2), 28–35. https://doi.org/10.1111/jhn.12133.CrossRefPubMed

29.

Lomer, M. C., Hart, A. L., Verjee, A., Daly, A., Solomon, J., & McLaughlin, J. (2017). What are the dietary treatment research priorities for inflammatory bowel disease? A short report based on a priority setting partnership with the James Lind Alliance. Journal of Human Nutrition and Dietetics, 30(6), 709–713. https://doi.org/10.1111/jhn.12494.CrossRefPubMed

30.

Obih, C., Wahbeh, G., Lee, D., Braly, K., Giefer, M., Shaffer, M. L., et al. (2016). Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition, 32(4), 418–425. https://doi.org/10.1016/j.nut.2015.08.025.CrossRefPubMed

31.

Triggs, C. M., Munday, K., Hu, R., Fraser, A. G., Gearry, R. B., Barclay, M. L., et al. (2010). Dietary factors in chronic inflammation: Food tolerances and intolerances of a New Zealand Caucasian Crohn’s disease population. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 690(1–2), 123–138. https://doi.org/10.1016/j.mrfmmm.2010.01.020.CrossRefPubMed

32.

Cohen, A. B., Lee, D., Long, M. D., Kappelman, M. D., Martin, C. F., Sandler, R. S., et al. (2013). Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Digestive Diseases and Sciences, 58(5), 1322–1328. https://doi.org/10.1007/s10620-012-2373-3.CrossRefPubMed

33.

Cooper, J. M., Collier, J., James, V., & Hawkey, C. J. (2010). Beliefs about personal control and self-management in 30–40 year olds living with inflammatory bowel disease: A qualitative study. International Journal of Nursing Studies, 47(12), 1500–1509. https://doi.org/10.1016/j.ijnurstu.2010.05.008.CrossRefPubMed

34.

Jamieson, A. E., Fletcher, P. C., & Schneider, M. A. (2007). Seeking control through the determination of diet: A qualitative investigation of women with irritable bowel syndrome and inflammatory bowel disease. Clinical Nurse Specialist, 21(3), 152–160. https://doi.org/10.1097/01.NUR.0000270015.97457.9c.CrossRefPubMed

35.

Hughes, L. D., King, L., Morgan, M., Ayis, S., Direkze, N., Lomer, M. C., et al. (2016). Food-related quality of life in inflammatory bowel disease: Development and validation of a questionnaire. Journal of Crohn’s and Colitis, 10(2), 194–201. https://doi.org/10.1093/ecco-jcc/jjv192.CrossRefPubMed

36.

Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods, 39(2), 175–191.CrossRef

37.

Bernstein, C. N., Fried, M., Krabshuis, J., Cohen, H., Eliakim, R., Fedail, S., et al. (2010). World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010. Inflammatory Bowel Diseases, 16(1), 112–124.CrossRef

38.

Drossman, D. A. (2006). The functional gastrointestinal disorders and the Rome III process. Gastroenterology, 130(5), 1377–1390. https://doi.org/10.1053/j.gastro.2006.03.008.CrossRefPubMed

39.

Harvey, R. F., & Bradshaw, M. J. (1980). Measuring Crohn’s disease activity. The Lancet, 1(8178), 1134–1135.CrossRef

40.

Marin-Jimenez, I., Nos, P., Domenech, E., Riestra, S., Gisbert, J. P., Calvet, X., et al. (2016). Diagnostic performance of the simple clinical colitis activity index self-administered online at home by patients with ulcerative colitis: CRONICA-UC study. American Journal of Gastroenterology, 111(2), 261–268. https://doi.org/10.1038/ajg.2015.403.CrossRefPubMed

41.

Walmsley, R., Ayres, R., Pounder, R., & Allan, R. (1998). A simple clinical colitis activity index. Gut, 43(1), 29–32.CrossRef

42.

Vermeire, S., Schreiber, S., Sandborn, W. J., Dubois, C., & Rutgeerts, P. (2010). Correlation between the Crohn’s disease activity and Harvey–Bradshaw indices in assessing Crohn’s disease severity. Clinical Gastroenterology and Hepatology, 8(4), 357–363. https://doi.org/10.1016/j.cgh.2010.01.001.CrossRefPubMed

43.

Drossman, D. A. (2006). Rome III: The new criteria. Chinese Journal of Digestive Diseases, 7(4), 181–185. https://doi.org/10.1111/j.1443-9573.2006.00265.x.CrossRefPubMed

44.

Francis, C. Y., Morris, J., & Whorwell, P. J. (1997). The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Alimentary Pharmacology and Therapeutics, 11(2), 395–402.CrossRef

45.

Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W. T., & Cella, D. (2011). Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS(R)): Depression, anxiety, and anger. Assessment, 18(3), 263–283. https://doi.org/10.1177/1073191111411667.CrossRefPubMedPubMedCentral

46.

Schalet, B. D., Pilkonis, P. A., Yu, L., Dodds, N., Johnston, K. L., Yount, S., et al. (2016). Clinical validity of PROMIS depression, anxiety, and anger across diverse clinical samples. Journal of Clinical Epidemiology, 73, 119–127. https://doi.org/10.1016/j.jclinepi.2015.08.036.CrossRefPubMedPubMedCentral

47.

Patrick, D. L., Drossman, D. A., Frederick, I. O., DiCesare, J., & Puder, K. L. (1998). Quality of life in persons with irritable bowel syndrome: Development and validation of a new measure. Digestive Diseases and Science, 43(2), 400–411.CrossRef

48.

Drossman, D., Morris, C. B., Hu, Y., Toner, B. B., Diamant, N., Whitehead, W. E., et al. (2007). Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. The American Journal of Gastroenterology, 102(7), 1442–1453. https://doi.org/10.1111/j.1572-0241.2007.01283.x.CrossRefPubMed

49.

Andrae, D. A., Patrick, D. L., Drossman, D. A., & Covington, P. S. (2013). Evaluation of the irritable bowel syndrome quality of life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients. Health and Quality of Life Outcomes, 11, 208–208. https://doi.org/10.1186/1477-7525-11-208.CrossRefPubMedPubMedCentral

50.

Jones, M. P., Bratten, J., & Keefer, L. (2007). Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet. The American Journal of Gastroenterology, 102(10), 2232–2237.CrossRef

51.

Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R., et al. (1989). A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 96(3), 804–810.CrossRef

52.

53.

Jones, M. P., Wessinger, S., & Crowell, M. D. (2006). Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease. Clinical Gastroenterology and Hepatology, 4(4), 474–481. https://doi.org/10.1016/j.cgh.2005.12.012.CrossRefPubMed

54.

Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale: Lawrence Erlbaum.

55.

Lee, E.-H., Kwon, O., Hahm, K. B., Kim, W., Kim, J. I., Cheung, D. Y., et al. (2016). Irritable bowel syndrome-specific health-related quality of life instrument: Development and psychometric evaluation. Health and Quality of Life Outcomes, 14, 22. https://doi.org/10.1186/s12955-016-0423-9.CrossRefPubMedPubMedCentral

56.

Vidal, A., Gomez-Gil, E., Sans, M., Portella, M. J., Salamero, M., Pique, J. M., et al. (2008). Health-related quality of life in inflammatory bowel disease patients: The role of psychopathology and personality. Inflammatory Bowel Diseases, 14(7), 977–983. https://doi.org/10.1002/ibd.20388.CrossRefPubMed

57.

Casellas, F., Rodrigo, L., Vivancos, J. L., Riestra, S., Pantiga, C., Baudet, J. S., et al. (2008). Factors that impact health-related quality of life in adults with celiac disease: A multicenter study. World Journal of Gastroenterology: WJG, 14(1), 46–52. https://doi.org/10.3748/wjg.14.46.CrossRefPubMed

58.

Norstrom, F., Lindholm, L., Sandstrom, O., Nordyke, K., & Ivarsson, A. (2011). Delay to celiac disease diagnosis and its implications for health-related quality of life. BMC Gastroenterology, 11, 118. https://doi.org/10.1186/1471-230x-11-118.CrossRefPubMedPubMedCentral

59.

Hauser, W., Gold, J., Stein, J., Caspary, W. F., & Stallmach, A. (2006). Health-related quality of life in adult coeliac disease in Germany: results of a national survey. European Journal of Gastroenterology & Hepatology, 18(7), 747–754. https://doi.org/10.1097/01.meg.0000221855.19201.e8.CrossRef

60.

Dassopoulos, T., Sultan, S., Falck-Ytter, Y. T., Inadomi, J. M., & Hanauer, S. B. (2013). American gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-alpha biologic drugs for the induction and maintenance of remission in inflammatory Crohn’s disease. Gastroenterology, 145(6), 1464–1478 e1461–1465. https://doi.org/10.1053/j.gastro.2013.10.046.CrossRefPubMed

61.

Maagaard, L., Ankersen, D. V., Végh, Z., Burisch, J., Jensen, L., Pedersen, N., et al. (2016). Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World Journal of Gastroenterology, 22(15), 4009–4019. https://doi.org/10.3748/wjg.v22.i15.4009.CrossRefPubMedPubMedCentral

62.

Prince, A. C., Myers, C. E., Joyce, T., Irving, P., Lomer, M., & Whelan, K. (2016). Fermentable carbohydrate restriction (Low FODMAP Diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 22(5), 1129–1136. https://doi.org/10.1097/mib.0000000000000708.CrossRefPubMed

63.

Wolf, W. A., Jerath, M. R., Sperry, S. L. W., Shaheen, N. J., & Dellon, E. S. (2014). Dietary Elimination therapy is an effective option for adults with eosinophilic esophagitis. Clinical Gastroenterology and Hepatology: The official clinical practice journal of the American Gastroenterological Association, 12(8), 1272–1279. https://doi.org/10.1016/j.cgh.2013.12.034.CrossRef

64.

Gonsalves, N., Yang, G. Y., Doerfler, B., Ritz, S., Ditto, A. M., & Hirano, I. (2012). Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology, 142(7), 1451–1459.e1451. https://doi.org/10.1053/j.gastro.2012.03.001.CrossRefPubMed

65.

Menard-Katcher, P., Marks, K. L., Liacouras, C. A., Spergel, J. M., Yang, Y. X., & Falk, G. W. (2013). The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood. Alimentary Pharmacology & Therapeutics, 37(1), 114–121. https://doi.org/10.1111/apt.12119.CrossRef

66.

Knowles, S. R., Gass, C., & Macrae, F. (2013). Illness perceptions in IBD influence psychological status, sexual health and satisfaction, body image and relational functioning: A preliminary exploration using structural equation modeling. Journal of Crohn’s and Colitis, 7(9), e344–e350. https://doi.org/10.1016/j.crohns.2013.01.018.CrossRefPubMed

Titel: Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome
verfasst von: Livia Guadagnoli
Ece A. Mutlu
Bethany Doerfler
Ammoura Ibrahim
Darren Brenner
Tiffany H. Taft
Publikationsdatum: 21.03.2019
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 8/2019
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-019-02170-4

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome

Abstract

Background

Methods

Results

Conclusion

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2019

Development of a quality of life questionnaire for nursing home residents in mainland China

Comparing internet and face-to-face surveys as methods for eliciting preferences for social care-related quality of life: evidence from England using the ASCOT service user measure

Correction to: Main and interactive effects of inflammation and perceived neighbourhood cohesion on psychological distress: results from a population-based study in the UK

Health-related quality of life and perceived health status of Turkish population

Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries

Factors associated with low health-related quality of life among younger and older Thai patients with non-valvular atrial fibrillation